These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22819196)

  • 1. Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
    Cornelissen B; Darbar S; Kersemans V; Allen D; Falzone N; Barbeau J; Smart S; Vallis KA
    Nucl Med Biol; 2012 Nov; 39(8):1142-51. PubMed ID: 22819196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
    Terry SY; Vallis KA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1298-305. PubMed ID: 22336201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
    Cornelissen B; Kersemans V; Darbar S; Thompson J; Shah K; Sleeth K; Hill MA; Vallis KA
    Cancer Res; 2011 Jul; 71(13):4539-49. PubMed ID: 21586614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
    Cornelissen B; Waller A; Able S; Vallis KA
    Mol Cancer Ther; 2013 Nov; 12(11):2472-82. PubMed ID: 23963362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
    Knight JC; Topping C; Mosley M; Kersemans V; Falzone N; Fernández-Varea JM; Cornelissen B
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1707-1717. PubMed ID: 26031435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
    Cai Z; Chen Z; Bailey KE; Scollard DA; Reilly RM; Vallis KA
    J Nucl Med; 2008 Aug; 49(8):1353-61. PubMed ID: 18632822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
    Costantini DL; Villani DF; Vallis KA; Reilly RM
    J Nucl Med; 2010 Mar; 51(3):477-83. PubMed ID: 20150272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
    Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
    J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Cell Cytotoxicity and Comet Assay on HER2/neu Positive Cell Line Due to
    Piroozfar B; Alirezapour B; Sedeh FM; Mirzaii M; Jalilian AR; Hashemizadeh M; Raisali G
    Curr Radiopharm; 2022; 15(2):148-156. PubMed ID: 34182918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
    Costantini DL; Chan C; Cai Z; Vallis KA; Reilly RM
    J Nucl Med; 2007 Aug; 48(8):1357-68. PubMed ID: 17631548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.
    Cornelissen B; Able S; Kartsonaki C; Kersemans V; Allen PD; Cavallo F; Cazier JB; Iezzi M; Knight J; Muschel R; Smart S; Vallis KA
    J Nucl Med; 2014 Dec; 55(12):2026-31. PubMed ID: 25453049
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Poty S; Mandleywala K; O'Neill E; Knight JC; Cornelissen B; Lewis JS
    Theranostics; 2020; 10(13):5802-5814. PubMed ID: 32483420
    [No Abstract]   [Full Text] [Related]  

  • 16. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
    Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
    J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging DNA Damage Repair In Vivo After
    O'Neill E; Kersemans V; Allen PD; Terry SYA; Torres JB; Mosley M; Smart S; Lee BQ; Falzone N; Vallis KA; Konijnenberg MW; de Jong M; Nonnekens J; Cornelissen B
    J Nucl Med; 2020 May; 61(5):743-750. PubMed ID: 31757844
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
    Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
    Cornelissen B; Waller A; Target C; Kersemans V; Smart S; Vallis KA
    EJNMMI Res; 2012 Feb; 2():9. PubMed ID: 22348532
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.